PharmaShots | Incisive News in 3 Shots

Subscribe Now

Seven

Takeda and Neurocrine Collaborate for Seven Neuro Programs Worth Up to $2B

Takeda and Neurocrine Collaborate for Seven Neuro Programs Worth Up to $2B

June 17, 2020

STADA Signs an Exclusive Commercialization Agreement with Alvotech for Seven Biosimilars in Europe

STADA Signs an Exclusive Commercialization Agreement with Alvotech for Seven Biosimilars in Europe

November 7, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us